Ohki Health Care Holdings, Inc. (3417) AI Stock Analysis

• Market Cap: ¥19.07B
• Dividend Yield: 1.88%
• Average Volume (3M): 13.86K
• Price to Earnings (P/E): 6.7
• Beta (1Y): 0.61
• Revenue Growth: 3.70%
• EPS Growth: 37.00%
• Country: JP
• Employees: 632
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Pharmaceuticals
• EPS (TTM): 43.62
• Shares Outstanding: 14,072,100
• 10 Day Avg. Volume: 10,200
• 30 Day Avg. Volume: 13,863
• PEG Ratio: 0.20
• Price to Book (P/B): 0.35
• Price to Sales (P/S): 0.03
• P/FCF Ratio: -0.91
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥1,326.00
• Price Target Upside: -4.12% Downside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0

• Rating: 75 Outperform
• Price Target: ¥1,326.00 ▼(-4.12% Downside)

Ohki Health Care Holdings, Inc. receives a strong overall score due to its robust technical indicators and attractive valuation. However, financial performance concerns, particularly around leverage and cash flow, temper the score. Investors should consider the potential for short-term volatility due to overbought technical signals.

Ohki Health Care Holdings, Inc. Business Overview & Revenue Model

Company Description

Ohki Health Care Holdings, Inc. (3417) is a company that operates in the health care sector, focusing on the development, production, and distribution of pharmaceutical products. The company offers a range of health-related products, including prescription medications, over-the-counter drugs, and health supplements. Its operations are primarily based in Japan, where it serves a diverse customer base through various distribution channels.

How the Company Makes Money

Ohki Health Care Holdings, Inc. generates revenue through the sale of its pharmaceutical products and health supplements. The company's key revenue streams include the domestic and international sales of prescription and over-the-counter medications. Additionally, partnerships with healthcare providers and distribution agreements with pharmacies and retailers contribute to its earnings. The company also invests in research and development to innovate and expand its product offerings, which can lead to increased market share and profitability. Significant factors affecting its revenue include regulatory approvals, market demand for health-related products, and the company's ability to effectively market and distribute its products.

Ohki Health Care Holdings, Inc. Financial Statement Overview

Summary

Ohki Health Care Holdings, Inc. shows strong revenue growth and improved operational efficiency. However, increased leverage and negative free cash flow in the latest year are concerning, indicating a need for better profitability and cash flow management.

Income Statement

Ohki Health Care Holdings, Inc. has shown consistent revenue growth over the years, with a notable increase from 2024 to 2025. The gross profit margin has been stable, indicating efficient cost management. However, the net profit margin is relatively low, suggesting room for improvement in profitability. EBIT and EBITDA margins have improved, reflecting better operational efficiency.

Balance Sheet

The company's debt-to-equity ratio has increased, indicating higher leverage, which could pose a risk if not managed properly. Return on equity has been positive, showing the company is generating profits from shareholders' investments. The equity ratio indicates a moderate level of financial stability, but the increase in total debt warrants caution.

Cash Flow

The cash flow statement reveals challenges, with negative free cash flow in the latest year, indicating potential liquidity issues. The operating cash flow to net income ratio is negative, suggesting cash flow management needs improvement. Despite these concerns, the company has managed to maintain positive operating cash flows in previous years.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	352.90B	349.45B	334.66B	304.44B	278.16B	270.93B
Gross Profit	19.01B	18.19B	17.20B	15.88B	13.72B	15.51B
EBITDA	4.61B	4.29B	3.82B	3.59B	1.95B	4.50B
Net Income	2.83B	2.64B	2.21B	2.18B	972.00M	2.75B
Balance Sheet
Total Assets	141.50B	139.34B	138.58B	122.54B	113.95B	110.96B
Cash, Cash Equivalents and Short-Term Investments	3.49B	2.88B	8.31B	3.24B	2.77B	2.80B
Total Debt	13.41B	14.17B	6.95B	8.46B	7.48B	8.59B
Total Liabilities	110.48B	108.28B	110.68B	98.27B	91.86B	88.82B
Stockholders Equity	30.96B	30.99B	27.84B	24.13B	21.95B	21.93B
Cash Flow
Free Cash Flow	0.00	-12.03B	7.23B	-223.00M	1.17B	-4.43B
Operating Cash Flow	0.00	-9.18B	7.55B	96.00M	1.31B	-4.27B
Investing Cash Flow	0.00	-3.13B	-496.00M	-291.00M	68.00M	710.00M
Financing Cash Flow	0.00	6.89B	-2.00B	681.00M	-1.40B	2.36B

Ohki Health Care Holdings, Inc. Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 1383.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3417, the sentiment is Neutral. The current price of 1383 is below the 20-day moving average (MA) of 1384.75, above the 50-day MA of 1292.92, and above the 200-day MA of 984.40, indicating a neutral trend. The MACD of 30.30 indicates Positive momentum. The RSI at 58.21 is Neutral, neither overbought nor oversold. The STOCH value of 27.13 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:3417.

Ohki Health Care Holdings, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3417	75 Outperform	¥19.07B	6.66	―	1.88%	3.70%	37.00%
7679	74 Outperform	¥44.44B	10.39	11.53%	1.24%	6.65%	12.77%
3544	67 Neutral	¥11.14B	15.22	7.83%	1.24%	4.08%	51.63%
4350	63 Neutral	¥14.00B	11.89	7.77%	2.52%	5.93%	-36.11%
8095	60 Neutral	¥20.70B	-10.62	-10.03%	3.51%	12.75%	-191.21%
2796	58 Neutral	¥6.15B	-23.44	-5.34%	2.67%	15.66%	56.93%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%